Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyBiologicalProcessnuclear-transcribed mRNA catabolic process

A1CF YBX1 NCBP1 CAPRIN1 HNRNPU SAMD4A

6.24e-06132716GO:0000956
GeneOntologyBiologicalProcessmRNA catabolic process

YBX2 A1CF YBX1 NCBP1 PUM1 CAPRIN1 HNRNPU SAMD4A

4.18e-05373718GO:0006402
GeneOntologyBiologicalProcesspositive regulation of collagen fibril organization

EFEMP2 TNXB

6.98e-054712GO:1904028
GeneOntologyBiologicalProcessnuclear-transcribed mRNA catabolic process, deadenylation-dependent decay

YBX1 CAPRIN1 HNRNPU SAMD4A

7.45e-0565714GO:0000288
GeneOntologyBiologicalProcessregulation of mRNA catabolic process

YBX2 A1CF YBX1 PUM1 CAPRIN1 HNRNPU SAMD4A

9.26e-05309717GO:0061013
GeneOntologyBiologicalProcessRNA catabolic process

YBX2 A1CF YBX1 NCBP1 PUM1 CAPRIN1 HNRNPU SAMD4A

1.16e-04432718GO:0006401
GeneOntologyBiologicalProcessregulation of mRNA metabolic process

YBX2 A1CF YBX1 NCBP1 PUM1 CAPRIN1 HNRNPU SAMD4A

1.38e-04443718GO:1903311
GeneOntologyBiologicalProcessnucleic acid catabolic process

YBX2 A1CF YBX1 NCBP1 PUM1 CAPRIN1 HNRNPU SAMD4A

1.90e-04464718GO:0141188
GeneOntologyBiologicalProcessnegative regulation of mRNA catabolic process

YBX2 A1CF YBX1 HNRNPU

2.31e-0487714GO:1902373
GeneOntologyBiologicalProcesspositive regulation of mRNA metabolic process

YBX1 NCBP1 PUM1 CAPRIN1 HNRNPU SAMD4A

2.68e-04259716GO:1903313
GeneOntologyBiologicalProcessregulation of translation

YBX2 YBX1 MTIF2 NCBP1 PUM1 CAPRIN1 HNRNPU SAMD4A

2.90e-04494718GO:0006417
GeneOntologyCellularComponentCRD-mediated mRNA stability complex

YBX1 HNRNPU

1.79e-046732GO:0070937
GeneOntologyCellularComponentcytoplasmic ribonucleoprotein granule

YBX1 KIF3C PUM1 CAPRIN1 HNRNPU SAMD4A

3.55e-04269736GO:0036464
GeneOntologyCellularComponentP-body

YBX1 PUM1 CAPRIN1 SAMD4A

4.49e-04102734GO:0000932
GeneOntologyCellularComponentexternal encapsulating structure

SNED1 FBN1 DST EFEMP2 ADAMTS17 LAMA2 HAPLN3 PKHD1L1 TNXB

4.62e-04658739GO:0030312
GeneOntologyCellularComponentribonucleoprotein granule

YBX1 KIF3C PUM1 CAPRIN1 HNRNPU SAMD4A

5.01e-04287736GO:0035770
GeneOntologyCellularComponentneuron projection cytoplasm

DST GRIA2 KIF3C HNRNPU

5.98e-04110734GO:0120111
GeneOntologyCellularComponentdendrite

ERBB4 YBX1 LAMA2 GRIA2 APLP2 KIF3C GRM3 CAPRIN1 HNRNPU SAMD4A

7.68e-048587310GO:0030425
GeneOntologyCellularComponentdendritic tree

ERBB4 YBX1 LAMA2 GRIA2 APLP2 KIF3C GRM3 CAPRIN1 HNRNPU SAMD4A

7.82e-048607310GO:0097447
GeneOntologyCellularComponentbasement membrane

FBN1 DST EFEMP2 LAMA2

8.81e-04122734GO:0005604
GeneOntologyCellularComponentmicrofibril

FBN1 EFEMP2

9.15e-0413732GO:0001527
GeneOntologyCellularComponentprotein complex involved in cell-matrix adhesion

LAMA2 TNXB

1.58e-0317732GO:0098637
GeneOntologyCellularComponentextracellular matrix

SNED1 FBN1 DST EFEMP2 ADAMTS17 LAMA2 HAPLN3 TNXB

2.01e-03656738GO:0031012
DomainPectin_lyase_fold/virulence

FBXO11 PKHD1L1 CEMIP2

3.16e-068733IPR011050
DomainEGF-like_dom

SNED1 FBN1 CELSR2 EFEMP2 LAMA2 ADAM29 C7 TNXB

5.68e-06249738IPR000742
DomainEGF_1

SNED1 FBN1 CELSR2 EFEMP2 LAMA2 ADAM29 C7 TNXB

6.76e-06255738PS00022
DomainEGF-like_CS

SNED1 FBN1 CELSR2 EFEMP2 LAMA2 ADAM29 C7 TNXB

8.01e-06261738IPR013032
DomainEGF_2

SNED1 FBN1 CELSR2 EFEMP2 LAMA2 ADAM29 C7 TNXB

8.95e-06265738PS01186
DomainEGF_3

SNED1 FBN1 CELSR2 EFEMP2 ADAM29 C7 TNXB

3.67e-05235737PS50026
DomainG8

PKHD1L1 CEMIP2

9.00e-054732PF10162
DomainG8_domain

PKHD1L1 CEMIP2

9.00e-054732IPR019316
DomainG8

PKHD1L1 CEMIP2

9.00e-054732PS51484
DomainG8

PKHD1L1 CEMIP2

9.00e-054732SM01225
DomainCOLD_SHOCK

YBX2 YBX1

2.24e-046732PS00352
DomainPbH1

FBXO11 PKHD1L1

2.24e-046732SM00710
DomainCold-shock_CS

YBX2 YBX1

2.24e-046732IPR019844
DomainPbH1

FBXO11 PKHD1L1

2.24e-046732IPR006626
DomainEGF

SNED1 FBN1 CELSR2 EFEMP2 LAMA2 TNXB

3.14e-04235736SM00181
DomainGrowth_fac_rcpt_

ERBB4 FBN1 CELSR2 EFEMP2 TNXB

3.62e-04156735IPR009030
DomainCSP

YBX2 YBX1

4.16e-048732SM00357
DomainCold_shock_prot

YBX2 YBX1

4.16e-048732IPR011129
DomainCSD

YBX2 YBX1

4.16e-048732PF00313
DomainCSP_DNA-bd

YBX2 YBX1

4.16e-048732IPR002059
DomainASX_HYDROXYL

SNED1 FBN1 CELSR2 EFEMP2

6.34e-04100734PS00010
DomainEGF-type_Asp/Asn_hydroxyl_site

SNED1 FBN1 CELSR2 EFEMP2

7.90e-04106734IPR000152
DomainMBOAT_fam

MBOAT2 DGAT1

8.10e-0411732IPR004299
DomainMBOAT

MBOAT2 DGAT1

8.10e-0411732PF03062
DomainUBX

UBXN4 NSFL1C

9.70e-0412732SM00166
DomainUBX

UBXN4 NSFL1C

1.14e-0313732PF00789
DomainUBX

UBXN4 NSFL1C

1.14e-0313732PS50033
DomainUBX_dom

UBXN4 NSFL1C

1.14e-0313732IPR001012
DomainCCP

SNED1 C7 CSMD3

1.23e-0354733SM00032
DomainEGF_CA

SNED1 FBN1 CELSR2 EFEMP2

1.33e-03122734SM00179
DomainSUSHI

SNED1 C7 CSMD3

1.37e-0356733PS50923
DomainEGF-like_Ca-bd_dom

SNED1 FBN1 CELSR2 EFEMP2

1.41e-03124734IPR001881
DomainSushi_SCR_CCP_dom

SNED1 C7 CSMD3

1.44e-0357733IPR000436
DomainTSP_1

ADAMTS17 C7 THSD1

1.92e-0363733PF00090
DomainTSP1

ADAMTS17 C7 THSD1

2.10e-0365733SM00209
DomainTSP1_rpt

ADAMTS17 C7 THSD1

2.10e-0365733IPR000884
DomainTSP1

ADAMTS17 C7 THSD1

2.10e-0365733PS50092
Domain-

SPINT2 APLP2

2.21e-03187324.10.410.10
DomainPrtase_inh_Kunz-CS

SPINT2 APLP2

2.21e-0318732IPR020901
DomainKU

SPINT2 APLP2

2.21e-0318732SM00131
DomainBPTI_KUNITZ_2

SPINT2 APLP2

2.47e-0319732PS50279
DomainKunitz_BPTI

SPINT2 APLP2

2.47e-0319732PF00014
DomainBPTI_KUNITZ_1

SPINT2 APLP2

2.47e-0319732PS00280
DomainKunitz_BPTI

SPINT2 APLP2

3.61e-0323732IPR002223
Pubmed

UBXD7 binds multiple ubiquitin ligases and implicates p97 in HIF1alpha turnover.

UBXN4 NSFL1C WDR26 NPLOC4 KLHL22

2.09e-076273518775313
Pubmed

CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality.

ZKSCAN1 YBX1 NCBP1 NOL9 API5 FLG2 VIRMA CAPRIN1 HNRNPU VDAC2

5.47e-07605731028977666
Pubmed

Tissue-Specific Regulation of the Wnt/β-Catenin Pathway by PAGE4 Inhibition of Tankyrase.

IVNS1ABP FASN YBX1 TAB1 WDR26 HNRNPU VDAC2

1.16e-0625673732698014
Pubmed

SND1 binds SARS-CoV-2 negative-sense RNA and promotes viral RNA synthesis through NSP9.

A1CF DST YBX1 API5 PUM1 CAPRIN1 CNN2

1.22e-0625873737794589
Pubmed

Deubiquitinating enzyme PSMD14 promotes tumor metastasis through stabilizing SNAIL in human esophageal squamous cell carcinoma.

IVNS1ABP DOCK4 FASN YBX1 TAB1 WDR26 HNRNPU VDAC2

1.45e-0638373829331416
Pubmed

Cellular RNA binding proteins NS1-BP and hnRNP K regulate influenza A virus RNA splicing.

IVNS1ABP YBX1 NCBP1 HNRNPU

1.54e-064073423825951
Pubmed

A central chaperone-like role for 14-3-3 proteins in human cells.

IVNS1ABP DOCK4 CRTC3 ERBB4 DST TAB1 PUM1 WDR26 VIRMA NSD3 SAMD4A

1.77e-06861731136931259
Pubmed

Quantitative study of the interactome of PKCζ involved in the EGF-induced tumor cell chemotaxis.

DOCK4 FASN YBX1 TAB1 TEX15 WDR26

2.56e-0618473623402259
Pubmed

Neuron-specific protein network mapping of autism risk genes identifies shared biological mechanisms and disease-relevant pathologies.

DOCK4 ERBB4 UBXN4 NSFL1C CELSR2 YBX1 GRIA2 TAB1 ALDH6A1 WDR26 CAPRIN1 HNRNPU

4.19e-061139731236417873
Pubmed

Internalization of AMPA-type Glutamate Receptor in the MIN6 Pancreatic β-cell Line.

GRIA2 GRM3

4.35e-06273232581155
Pubmed

A novel ADAMTS17 variant that causes Weill-Marchesani syndrome 4 alters fibrillin-1 and collagen type I deposition in the extracellular matrix.

FBN1 ADAMTS17

4.35e-06273231726086
Pubmed

Mammalian male and female germ cells express a germ cell-specific Y-Box protein, MSY2.

YBX2 YBX1

4.35e-0627329780336
Pubmed

TSH/TSHR Signaling Suppresses Fatty Acid Synthase (FASN) Expression in Adipocytes.

FASN TSHR

4.35e-06273225655684
Pubmed

Mapping the mammalian ribosome quality control complex interactome using proximity labeling approaches.

IVNS1ABP DOCK4 UBXN4 NSFL1C YBX1 NPLOC4

4.39e-0620273629540532
Pubmed

HDLBP Promotes Hepatocellular Carcinoma Proliferation and Sorafenib Resistance by Suppressing Trim71-dependent RAF1 Degradation.

FASN A1CF YBX1 PEG3 FBXO11 NCBP1 NOL9 FLG2 VIRMA CAPRIN1 CNN2 NPLOC4 VDAC2

5.00e-061371731336244648
Pubmed

Proteomic identification of common SCF ubiquitin ligase FBXO6-interacting glycoproteins in three kinds of cells.

IVNS1ABP FASN YBX1 B3GALNT2 FLG2 PUM1 CAPRIN1 CEMIP2 VDAC2

5.51e-0661373922268729
Pubmed

New roles for the de-ubiquitylating enzyme OTUD4 in an RNA-protein network and RNA granules.

ZKSCAN1 YBX1 FBXO11 NCBP1 WDR26 CAPRIN1 HNRNPU SAMD4A

5.76e-0646273831138677
Pubmed

Cold shock domain family members YB-1 and MSY4 share essential functions during murine embryogenesis.

YBX2 YBX1

1.30e-05373216954378
Pubmed

The lipogenic enzymes DGAT1, FAS, and LPL in adipose tissue: effects of obesity, insulin resistance, and TZD treatment.

FASN DGAT1

1.30e-05373216894240
Pubmed

Moderate and high amounts of tamoxifen in αMHC-MerCreMer mice induce a DNA damage response, leading to heart failure and death.

ERBB4 A1CF

1.30e-05373223929941
Pubmed

CircRNA MBOAT2 promotes intrahepatic cholangiocarcinoma progression and lipid metabolism reprogramming by stabilizing PTBP1 to facilitate FASN mRNA cytoplasmic export.

FASN MBOAT2

1.30e-05373236635270
Pubmed

The Role of Diacylglycerol Acyltransferase (DGAT) 1 and 2 in Cardiac Metabolism and Function.

A1CF DGAT1

1.30e-05373229563512
Pubmed

Global proteomics of Ubqln2-based murine models of ALS.

DST NSFL1C YBX1 TAB1 CNN2 NPLOC4

1.88e-0526173633277362
Pubmed

Arginine methylation and ubiquitylation crosstalk controls DNA end-resection and homologous recombination repair.

IVNS1ABP FASN YBX1 TAB1 API5 WDR26 CAPRIN1 HNRNPU

2.05e-0555173834728620
Pubmed

Homologous Transcription Factors DUX4 and DUX4c Associate with Cytoplasmic Proteins during Muscle Differentiation.

FASN FBN1 YBX1 CAPRIN1 HNRNPU VDAC2

2.33e-0527173626816005
Pubmed

Systematic proteomics of endogenous human cohesin reveals an interaction with diverse splicing factors and RNA-binding proteins required for mitotic progression.

FASN TAB1 FLG2 WDR26 CAPRIN1 HNRNPU

2.38e-0527273631010829
Pubmed

Elastogenic protein expression of a highly elastic murine spinal ligament: the ligamentum flavum.

FBN1 EFEMP2

2.60e-05473222685574
Pubmed

Sequence and conformational specificity in substrate recognition: several human Kunitz protease inhibitor domains are specific substrates of mesotrypsin.

SPINT2 APLP2

2.60e-05473225301953
Pubmed

YB-1 binds to GluR2 mRNA and CaM1 mRNA in the brain and regulates their translational levels in an activity-dependent manner.

YBX1 GRIA2

2.60e-05473220614234
Pubmed

Weill-Marchesani Syndrome

FBN1 ADAMTS17

2.60e-05473220301293
Pubmed

Anxiolytic-like activity of the mGLU2/3 receptor agonist LY354740 in the elevated plus maze test is disrupted in metabotropic glutamate receptor 2 and 3 knock-out mice.

GRIA2 GRM3

2.60e-05473215619115
Pubmed

ATPase activity of p97/valosin-containing protein is regulated by oxidative modification of the evolutionally conserved cysteine 522 residue in Walker A motif.

NSFL1C NPLOC4

2.60e-05473216234241
Pubmed

Effects of mGlu2 or mGlu3 receptor deletions on mGlu2/3 receptor agonist (LY354740)-induced brain c-Fos expression: specific roles for mGlu2 in the amygdala and subcortical nuclei, and mGlu3 in the hippocampus.

GRIA2 GRM3

2.60e-05473216733060
Pubmed

Use of MGLUR2 and MGLUR3 knockout mice to explore in vivo receptor specificity of the MGLUR2/3 selective antagonist LY341495.

GRIA2 GRM3

2.60e-05473219477188
Pubmed

Tumor suppressor BAP1 nuclear import is governed by transportin-1.

IVNS1ABP FASN DST NSFL1C YBX1 TAB1 NOL9 API5 WDR26 CAPRIN1 HNRNPU

2.66e-051149731135446349
Pubmed

Interaction between host G3BP and viral nucleocapsid protein regulates SARS-CoV-2 replication and pathogenicity.

YBX1 CAPRIN1 HNRNPU

2.80e-052873338492217
Pubmed

Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.

DST CELSR2 ZKSCAN1 GRIA2 NOL9 GRM3 WDR26 VIRMA CAPRIN1 HNRNPU

3.24e-05963731028671696
Pubmed

The interactome of metabolic enzyme carbonic anhydrase IX reveals novel roles in tumor cell migration and invadopodia/MMP14-mediated invasion.

UBXN4 SPINT2 APLP2 MBOAT2 CEMIP2

3.56e-0517673528692057
Pubmed

Defining the proximal interaction networks of Arf GTPases reveals a mechanism for the regulation of PLD1 and PI4KB.

UBXN4 DST YBX1 RPGR FLG2 PCDH10 PKHD1L1 PCDH9 CEMIP2

3.59e-0577773935844135
Pubmed

Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.

IVNS1ABP FASN YBX1 NCBP1 APLP2 KIF3C NOL9 API5 PUM1 CAPRIN1 HNRNPU VDAC2

3.88e-051425731230948266
Pubmed

Proline-rich sequence recognition: II. Proteomics analysis of Tsg101 ubiquitin-E2-like variant (UEV) interactions.

FASN WDR26 CAPRIN1

4.21e-053273319542561
Pubmed

A protein-interaction network of interferon-stimulated genes extends the innate immune system landscape.

FASN DST YBX1 DAB2 TRAPPC10 NCBP1 WDR26 CAPRIN1 NPLOC4 HNRNPU VDAC2 SAMD4A

4.30e-051440731230833792
Pubmed

Direct binding of ubiquitin conjugates by the mammalian p97 adaptor complexes, p47 and Ufd1-Npl4.

NSFL1C NPLOC4

4.33e-05573212411482
Pubmed

Neuregulin1/ErbB4 signaling induces cardiomyocyte proliferation and repair of heart injury.

ERBB4 A1CF

4.33e-05573219632177
Pubmed

Pathogenic Mutations in the Valosin-containing Protein/p97(VCP) N-domain Inhibit the SUMOylation of VCP and Lead to Impaired Stress Response.

NSFL1C NPLOC4

4.33e-05573227226613
Pubmed

Fibrillin-1 interactions with fibulins depend on the first hybrid domain and provide an adaptor function to tropoelastin.

FBN1 EFEMP2

4.33e-05573217255108
Pubmed

A complex of mammalian ufd1 and npl4 links the AAA-ATPase, p97, to ubiquitin and nuclear transport pathways.

NSFL1C NPLOC4

4.33e-05573210811609
Pubmed

Differential regulation of elastic fiber formation by fibulin-4 and -5.

FBN1 EFEMP2

4.33e-05573219570982
Pubmed

PEG3 controls lipogenesis through ACLY.

FASN PEG3

4.33e-05573234048454
Pubmed

ZFP36L2 is a cell cycle-regulated CCCH protein necessary for DNA lesion-induced S-phase arrest.

IVNS1ABP YBX1 FBXO11 CAPRIN1 HNRNPU

5.00e-0518973529449217
Pubmed

Protein interaction profiling of the p97 adaptor UBXD1 points to a role for the complex in modulating ERGIC-53 trafficking.

DST NPLOC4 HNRNPU

5.53e-053573322337587
Pubmed

High-sensitivity profiling of SARS-CoV-2 noncoding region-host protein interactome reveals the potential regulatory role of negative-sense viral RNA.

YBX2 FASN A1CF YBX1 CAPRIN1 HNRNPU VDAC2

5.87e-0546973737314180
Pubmed

Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma.

FASN DST YBX1 NCBP1 NOL9 FLG2 VIRMA CAPRIN1 HNRNPU NSD3 VDAC2

6.00e-051257731136526897
Pubmed

Molecular composition of IMP1 ribonucleoprotein granules.

YBX1 NCBP1 HNRNPU

6.03e-053673317289661
Pubmed

Proteomic and genomic analysis of PITX2 interacting and regulating networks.

YBX1 HNRNPU

6.48e-05673219174163
Pubmed

Latent transforming growth factor beta-binding proteins and fibulins compete for fibrillin-1 and exhibit exquisite specificities in binding sites.

FBN1 EFEMP2

6.48e-05673219349279
Pubmed

Single-Cell Transcriptomics Reveals Regulators of Neuronal Migration and Maturation During Brain Development.

CELSR2 PCDH9

6.48e-05673229551912
Pubmed

VCP cooperates with UBXD1 to degrade mitochondrial outer membrane protein MCL1 in model of Huntington's disease.

NSFL1C NPLOC4

6.48e-05673227913212
Pubmed

Identification of proteins that interact with BRCA1 by Far-Western library screening.

PEG3 APLP2

6.48e-05673211746496
Pubmed

Hierarchical binding of cofactors to the AAA ATPase p97.

NSFL1C NPLOC4

6.48e-05673221645854
Pubmed

PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation.

FASN DST YBX1 FLG2 NPLOC4 HNRNPU VDAC2

6.52e-0547773731300519
Pubmed

SMYD3 Impedes Small Cell Lung Cancer Sensitivity to Alkylation Damage through RNF113A Methylation-Phosphorylation Cross-talk.

YBX2 CRTC3 FASN YBX1 PUM1 CAPRIN1 HNRNPU VDAC2

6.95e-0565573835819319
Pubmed

Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.

FBN1 DST CIAO3 MTIF2 EFEMP2 PEG3 FBXO11 NCBP1 WDR26 CAPRIN1 DSCAML1

7.31e-051285731135914814
Pubmed

MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons.

DST YBX1 FBXO11 NCBP1 APLP2 FLG2 TNXB HNRNPU NSD3 VDAC2

8.57e-051082731038697112
Pubmed

The intracellular interactome of tetraspanin-enriched microdomains reveals their function as sorting machineries toward exosomes.

YBX2 YBX1 CAPRIN1 CNN2 HNRNPU

8.61e-0521273523463506
Pubmed

DVC1 (C1orf124) recruits the p97 protein segregase to sites of DNA damage.

NSFL1C NPLOC4

9.06e-05773223042607
Pubmed

Staufen 1 is expressed by neural precursor cells in the developing murine cortex but is dispensable for NPC self-renewal and neuronal differentiation in vitro.

PUM1 SAMD4A

9.06e-05773234678304
Pubmed

Imbalances in p97 co-factor interactions in human proteinopathy.

NSFL1C NPLOC4

9.06e-05773220414249
Pubmed

Identification of FUBP1 as a Long Tail Cancer Driver and Widespread Regulator of Tumor Suppressor and Oncogene Alternative Splicing.

NCBP1 PUM1 VIRMA CAPRIN1

1.00e-0411473431553912
Pubmed

Cell cycle-dependent phosphorylation regulates RECQL4 pathway choice and ubiquitination in DNA double-strand break repair.

FASN YBX1 PEG3 NCBP1 API5 WDR26 CAPRIN1 CNN2 NPLOC4 HNRNPU VDAC2

1.02e-041335731129229926
Pubmed

Mass spectrometry-based proteomics revealed Glypican-1 as a novel ADAM17 substrate.

NSFL1C YBX1 CAPRIN1 HNRNPU

1.07e-0411673427576135
Pubmed

FAF1 phosphorylation by AKT accumulates TGF-β type II receptor and drives breast cancer metastasis.

NSFL1C YBX1 NPLOC4 HNRNPU VDAC2

1.11e-0422473528443643
Pubmed

Adamts17 is involved in skeletogenesis through modulation of BMP-Smad1/5/8 pathway.

FBN1 ADAMTS17

1.21e-04873231201465
Pubmed

Human ASPL/TUG interacts with p97 and complements the proteasome mislocalization of a yeast ubx4 mutant, but not the ER-associated degradation defect.

UBXN4 NSFL1C

1.21e-04873225078495
Pubmed

Control of c-myc mRNA stability by IGF2BP1-associated cytoplasmic RNPs.

YBX1 HNRNPU

1.21e-04873219029303
Pubmed

Interaction of two multifunctional proteins. Heterogeneous nuclear ribonucleoprotein K and Y-box-binding protein.

YBX1 HNRNPU

1.21e-04873210809782
Pubmed

The N-terminal domain of the Schaaf-Yang syndrome protein MAGEL2 likely has a role in RNA metabolism.

NSFL1C YBX1 HNRNPU

1.26e-044673334265304
Pubmed

Quantitative Proteomics Links the LRRC59 Interactome to mRNA Translation on the ER Membrane.

UBXN4 SPINT2 YBX1 CAPRIN1 NPLOC4 VDAC2

1.40e-0437573632788342
Pubmed

SNX27-driven membrane localisation of OTULIN antagonises linear ubiquitination and NF-κB signalling activation.

IVNS1ABP UBXN4 NSFL1C KIF3C TAB1 WDR26

1.46e-0437873634315543
Pubmed

The Activation-Induced Assembly of an RNA/Protein Interactome Centered on the Splicing Factor U2AF2 Regulates Gene Expression in Human CD4 T Cells.

YBX1 NCBP1 VIRMA CNN2 HNRNPU

1.51e-0423973526641092
Pubmed

Distribution of protocadherin 9 protein in the developing mouse nervous system.

PCDH10 PCDH9

1.55e-04973222982106
Pubmed

Ubiquitination of G3BP1 mediates stress granule disassembly in a context-specific manner.

CAPRIN1 NPLOC4

1.55e-04973234739333
Pubmed

The mouse poly(C)-binding protein exists in multiple isoforms and interacts with several RNA-binding proteins.

YBX2 YBX1

1.55e-0497328871564
Pubmed

Disabled-2 colocalizes with the LDLR in clathrin-coated pits and interacts with AP-2.

DAB2 APLP2

1.55e-04973211247302
Pubmed

SARS-CoV-2 N Protein Antagonizes Stress Granule Assembly and IFN Production by Interacting with G3BPs to Facilitate Viral Replication.

IVNS1ABP TAB1 API5 FLG2 HNRNPU

1.69e-0424573535652658
Pubmed

A Cross-Species Study of PI3K Protein-Protein Interactions Reveals the Direct Interaction of P85 and SHP2.

YBX1 CAPRIN1 VDAC2

1.72e-045173326839216
Pubmed

SPATA2 Links CYLD to LUBAC, Activates CYLD, and Controls LUBAC Signaling.

IVNS1ABP FASN YBX1 TAB1 FLG2 CAPRIN1 HNRNPU

1.72e-0455873727591049
Pubmed

Integrative genomics positions MKRN1 as a novel ribonucleoprotein within the embryonic stem cell gene regulatory network.

YBX1 CAPRIN1 HNRNPU

1.82e-045273326265008
Pubmed

Comparative proximity biotinylation implicates the small GTPase RAB18 in sterol mobilization and biosynthesis.

FASN UBXN4 DST DAB2 CNN2 NPLOC4 CEMIP2

1.92e-0456873737774976
Pubmed

E3 Ligase Trim21 Ubiquitylates and Stabilizes Keratin 17 to Induce STAT3 Activation in Psoriasis.

FASN DST FLG2 HNRNPU

1.92e-0413573429859926
Pubmed

Sleeping Beauty mutagenesis reveals cooperating mutations and pathways in pancreatic adenocarcinoma.

FBXO11 NSD3

1.93e-041073222421440
Pubmed

In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.

YBX2 FASN UBXN4 DST SUGCT YBX1 TTC16 CIAO3 GRIA2 NCBP1 HNRNPU

2.01e-041442731135575683
Pubmed

The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery.

FASN NSFL1C ZKSCAN1 YBX1 FBXO11 NCBP1 VIRMA CEMIP2 HNRNPU VDAC2

2.03e-041203731029180619
Pubmed

Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors.

SNED1 FASN UBXN4 FBN1 CELSR2 YBX1 MTIF2 EFEMP2 KIF3C HNRNPU VDAC2

2.12e-041451731130550785
Pubmed

The RNA-binding ubiquitin ligase MKRN1 functions in ribosome-associated quality control of poly(A) translation.

YBX1 PUM1 HNRNPU

2.15e-045573331640799
Pubmed

A high-throughput approach for measuring temporal changes in the interactome.

IVNS1ABP CRTC3 FASN NSFL1C YBX1 NCBP1 API5 WDR26 CNN2 NPLOC4 HNRNPU

2.17e-041455731122863883
Pubmed

Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.

DOCK4 PEG3 PUM1 CSMD3 PCDH10 VIRMA

2.18e-0440773612693553
Pubmed

A genome-wide association study of breast and prostate cancer in the NHLBI's Framingham Heart Study.

ERBB4 FBN1

2.36e-041173217903305
Pubmed

Do Gametes Woo? Evidence for Their Nonrandom Union at Fertilization.

A1CF PUM1

2.36e-041173228978771
Pubmed

Lipopenia and skin barrier abnormalities in DGAT2-deficient mice.

FASN DGAT1

2.36e-041173214668353
InteractionCSDE1 interactions

FASN YBX1 NCBP1 PUM1 VIRMA CAPRIN1 HNRNPU SAMD4A

8.57e-06284738int:CSDE1
InteractionZFP36L2 interactions

IVNS1ABP FASN YBX1 FBXO11 PUM1 CAPRIN1 HNRNPU

1.13e-05211737int:ZFP36L2
Cytoband5p13

DAB2 C7

3.34e-04177325p13
GeneFamilyY box binding proteins

YBX2 YBX1

1.90e-053462106
GeneFamilyEF-hand domain containing|S100 fused type protein family

RPTN FLG2

1.32e-0474621350
GeneFamilyHyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing

SNED1 C7 CSMD3

4.10e-04574631179
GeneFamilyNon-clustered protocadherins

PCDH10 PCDH9

4.11e-041246221
GeneFamilyUBX domain containing

UBXN4 NSFL1C

4.85e-0413462364
GeneFamilyKelch like|BTB domain containing

IVNS1ABP KLHL22

5.11e-0342462617
GeneFamilyFibronectin type III domain containing

SNED1 TNXB DSCAML1

7.81e-03160463555
GeneFamilyEF-hand domain containing

DST RPTN FLG2

1.82e-02219463863
CoexpressionGSE3982_NEUTROPHIL_VS_TH1_UP

IVNS1ABP DOCK4 NSFL1C GRIA2 APLP2 WDR26

1.87e-05197736M5532
CoexpressionGSE339_CD4POS_VS_CD4CD8DN_DC_IN_CULTURE_UP

IVNS1ABP ERBB4 RPTN KIF3C TSHR HNRNPU

2.04e-05200736M5122
CoexpressionGSE16385_MONOCYTE_VS_12H_IL4_TREATED_MACROPHAGE_UP

IVNS1ABP SPINT2 RPTN TSHR GRM3 PCDH9

2.04e-05200736M7903
CoexpressionGSE5099_UNSTIM_VS_MCSF_TREATED_MONOCYTE_DAY3_DN

SNED1 FASN NXPE4 API5 PUM1 NPLOC4

2.04e-05200736M6583
CoexpressionGSE17721_LPS_VS_PAM3CSK4_16H_BMDC_DN

FASN YBX1 RPTN KIF3C ALDH6A1 DGAT1

2.04e-05200736M3929
CoexpressionNABA_MATRISOME_POORLY_METASTATIC_BREAST_CANCER

LAMA2 FLG2 TNXB

4.56e-0525733M47986
CoexpressionDUTERTRE_ESTRADIOL_RESPONSE_24HR_DN

FBN1 ATP8A1 ZKSCAN1 DAB2 MBOAT2 PCDH9 CNN2 SAMD4A

7.95e-05504738M2157
CoexpressionONDER_CDH1_TARGETS_2_UP

DOCK4 SNED1 FBN1 DAB2 ALDH6A1 PCDH9

8.24e-05257736M13867
ToppCellControl-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations)

DOCK4 FBN1 DST ABCA6 ADAMTS17 LAMA2 C7 TNXB

8.18e-1018773892d468dde81125d51daf7abd4703741abe1ab91c
ToppCellFetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

DOCK4 SNED1 FBN1 DST ABCA6 LAMA2 C7 CSMD3

1.09e-09194738011e14d9ed1393275f892060e7708ffadcd0767f
ToppCellCOVID-19-Fibroblasts-Alveolar_FB|COVID-19 / group, cell type (main and fine annotations)

SNED1 FBN1 DST ABCA6 ADAMTS17 LAMA2 C7 TNXB

1.14e-09195738603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7
ToppCellLung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Fibroblasts-1|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)

SNED1 FBN1 DST ABCA6 EFEMP2 LAMA2 C7 TNXB

1.39e-09200738c3d4ce70ab51d74c9fe2f5864e52a4a9d7570e10
ToppCellLung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Fibroblasts-1-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

SNED1 FBN1 DST ABCA6 EFEMP2 LAMA2 C7 TNXB

1.39e-09200738137f8f9d255c66336d4f8b44b2e3f3de721f2bf0
ToppCellParenchyma_COVID-19-Stromal-TX-Fibroblasts-1|Parenchyma_COVID-19 / Sample group, Lineage and Cell type

SNED1 FBN1 DST ABCA6 EFEMP2 LAMA2 C7 TNXB

1.39e-0920073825d3865aa2ced11a5ed40013e83b47d942fdf582
ToppCellCOVID-19-Heart-Fib_2|COVID-19 / Disease (COVID-19 only), tissue and cell type

SNED1 FBN1 ABCA6 LAMA2 C7 TNXB PCDH9

2.30e-081857378f95d8e591bf7379d13f5a0545b0cb49e2b1ab5d
ToppCelldroplet-Kidney-KIDNEY-1m-Mesenchymal-Stroma____fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

FBN1 EFEMP2 ADAMTS17 LAMA2 C7 GRM3 TNXB

2.30e-08185737785c55d39909fac74415f24427979691e7e694e6
ToppCelldroplet-Kidney-KIDNEY-1m-Mesenchymal|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

FBN1 EFEMP2 ADAMTS17 LAMA2 C7 GRM3 TNXB

2.30e-0818573797a1dcacbc48dc3f41c26fbb59af35c935f894d4
ToppCelldroplet-Kidney-KIDNEY-1m-Mesenchymal-fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

FBN1 EFEMP2 ADAMTS17 LAMA2 C7 GRM3 TNXB

2.38e-0818673794d577dbb6bfacf50632e1fe8af041b35a1e6b23
ToppCellControl-Fibroblasts-Other_FB|Control / group, cell type (main and fine annotations)

FBN1 DST ABCA6 SUGCT LAMA2 C7 TNXB

2.47e-08187737bd3739c4a52aa1ba5deffd778e113a9800f7e158
ToppCellCOVID-19-Heart-Fib_1|COVID-19 / Disease (COVID-19 only), tissue and cell type

SNED1 FBN1 ABCA6 LAMA2 C7 TNXB PCDH9

2.57e-08188737fe361215f4ba841aa5e1e581fb56f2f4d3ccd201
ToppCellnucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

FBN1 DST ABCA6 ADAMTS17 LAMA2 C7 TNXB

2.86e-081917376688cee34beee4f151ac17fccbc9c26a9aad72e1
ToppCellRV-01._Fibroblast_I|RV / Chamber and Cluster_Paper

SNED1 FBN1 ABCA6 ADAMTS17 LAMA2 C7 TNXB

2.97e-08192737356160b113c3305a61ceeaff33ce3c9da0be2878
ToppCellnucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

FBN1 DST ABCA6 ADAMTS17 LAMA2 C7 TNXB

2.97e-0819273799ce9e3c4c50cf64ebb62145f2b5420efa0db309
ToppCellChildren_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor

DOCK4 FBN1 DST ABCA6 ADAMTS17 LAMA2 TNXB

3.07e-0819373799525545552b371c86b18b6ea6f4897dc6e9a9ec
ToppCellChildren_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor

DOCK4 FBN1 DST ABCA6 ADAMTS17 LAMA2 TNXB

3.18e-08194737e93de9428c986b8943fc169258847c650cfab0e5
ToppCell3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

SNED1 FBN1 DST ABCA6 LAMA2 C7 TNXB

3.30e-08195737f54bc4454270ff06e85596f98199372b50d0179f
ToppCellnucseq-Mesenchymal-Fibroblastic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

FBN1 DST ABCA6 ADAMTS17 LAMA2 C7 TNXB

3.42e-081967377d8505dac15fa59935ccf592afc54b04c4c6554f
ToppCellCOVID-19-Fibroblasts-Intermediate_pathological_FB|COVID-19 / group, cell type (main and fine annotations)

SNED1 FBN1 DST ABCA6 SUGCT LAMA2 C7

3.54e-08197737f1c8936986123a3151140c374fcd62d6705c530b
ToppCellCOVID-19-Fibroblasts|COVID-19 / group, cell type (main and fine annotations)

SNED1 FBN1 DST ABCA6 SUGCT LAMA2 C7

3.54e-08197737fb847f2277609c31fffcdf49517243ce0684facf
ToppCelltumor_Lung-Fibroblasts-COL13A1+_matrix_FBs|tumor_Lung / Location, Cell class and cell subclass

FBN1 DST ABCA6 EFEMP2 LAMA2 C7 TNXB

3.66e-081987372d7842f352273b6b823c86eb548b9f4a4cddf0ae
ToppCellFetal_29-31_weeks-Mesenchymal|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

SNED1 FBN1 DST ABCA6 LAMA2 C7 SAMD4A

3.66e-0819873721cf4d81386761d09d0f6829c01c198e5524176d
ToppCellSmart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Perivascular_fibroblast|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

SNED1 FBN1 EFEMP2 LAMA2 C7 FLG2 CNN2

3.79e-08199737dfc5c7a4a093baa7158dd8d4d29a870d9c469a3f
ToppCellMesenchymal|World / Lineage, Cell type, age group and donor

SNED1 FBN1 DST ABCA6 LAMA2 C7 TNXB

3.79e-081997374bac110c2b3609f6ee5d0e3275da0824a6240270
ToppCellLPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type

FBN1 DST ABCA6 EFEMP2 ADAMTS17 C7 TNXB

3.79e-08199737a7dd94b172c973a131a6792f8ccd9bfe44d984ac
ToppCellLPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type

DOCK4 FBN1 DST ABCA6 EFEMP2 C7 TNXB

3.79e-0819973730d3e8c0681ec11f86dd38c5f48d21187a1b4f90
ToppCellSmart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Perivascular_fibroblast-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

SNED1 FBN1 EFEMP2 LAMA2 C7 FLG2 CNN2

3.79e-08199737c1760581c34b81d1d92c67500a1c8944e9cc6dad
ToppCellLPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type

DOCK4 FBN1 DST ABCA6 EFEMP2 C7 TNXB

3.92e-082007379b0916d8d07ac2bf1739f7be5296bf77ffee6094
ToppCellLung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Fibroblasts-2,_SCARA5-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

SNED1 FBN1 ABCA6 EFEMP2 LAMA2 C7 TNXB

3.92e-082007370b2614b8513693dd508c9003699049efd9abac52
ToppCellBronchial-NucSeq-Stromal-Fibroblastic-Fibro_adventitial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

SNED1 FBN1 ABCA6 LAMA2 C7 TNXB SAMD4A

3.92e-08200737ad3fdcef895400f929f2ae12ff9bd85fd46adb3a
ToppCell343B-Fibroblasts|343B / Donor, Lineage, Cell class and subclass (all cells)

FBN1 DST ABCA6 EFEMP2 LAMA2 C7 TNXB

3.92e-08200737376c1a77031e090be96948b47c78ac0d393f5775
ToppCellControl_saline-Mesenchymal_fibroblastic|Control_saline / Treatment groups by lineage, cell group, cell type

DOCK4 FBN1 ABCA6 EFEMP2 TEX15 C7 TNXB

3.92e-0820073764ae5cf6cb4fc94cf1052abd82648f6b8e6445fe
ToppCellBronchial-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

FBN1 DST ABCA6 LAMA2 C7 TNXB SAMD4A

3.92e-08200737389cc775c8419d90fb77cd794376d2160a7bf44e
ToppCellBronchial-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

DOCK4 FBN1 DST ABCA6 LAMA2 C7 TNXB

3.92e-08200737e8462395fee0a532d1e7ec7f1795f28c42af6541
ToppCellLung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Fibroblasts-2,_SCARA5|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)

SNED1 FBN1 ABCA6 EFEMP2 LAMA2 C7 TNXB

3.92e-082007378d2ceb2080c67b20f452eeca605aa27a58033c04
ToppCellParenchymal-10x3prime_v2-Stromal|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations

FBN1 DST ABCA6 EFEMP2 LAMA2 C7 TNXB

3.92e-08200737f6be0f24e607abb9007823a54fb0b24d04990a89
ToppCellTracheal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

SNED1 FBN1 ABCA6 LAMA2 C7 TNXB PCDH9

3.92e-08200737c318d14bd6fd6f42c597eb55ac9e2f48008aeb9b
ToppCellLPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type

FBN1 DST ABCA6 EFEMP2 C7 TNXB CEMIP2

3.92e-08200737a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2
ToppCellTracheal-10x5prime-Stromal-Fibroblastic-Fibro_adventitial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations

FBN1 ABCA6 EFEMP2 DAB2 LAMA2 C7 TNXB

3.92e-0820073774ad0ae592252060ee294d7483327d765a6ba1dd
ToppCellControl_saline-Mesenchymal_fibroblastic-Fibroblasts|Control_saline / Treatment groups by lineage, cell group, cell type

DOCK4 FBN1 ABCA6 EFEMP2 TEX15 C7 TNXB

3.92e-08200737a1fc74c1b27e104895910bc7cdce7ba33d30df7e
ToppCellFibroblast|World / shred by cell class for parenchyma

FBN1 DST ABCA6 EFEMP2 LAMA2 C7 TNXB

3.92e-08200737dec9ce1bc2571197003596f32e5f742ede72aa79
ToppCellParenchymal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

FBN1 DST ABCA6 ADAMTS17 LAMA2 C7 TNXB

3.92e-0820073734f52003988ce6329d8deeee1ab875fa77e01e9d
ToppCellTracheal-10x5prime-Stromal-Fibroblastic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations

FBN1 ABCA6 EFEMP2 DAB2 LAMA2 C7 TNXB

3.92e-082007377ba292c30d915e66ebc8026fa76492cedf64700e
ToppCellParenchyma_COVID-19-Stromal-TX-Fibroblasts-2,_SCARA5|Parenchyma_COVID-19 / Sample group, Lineage and Cell type

SNED1 FBN1 ABCA6 EFEMP2 LAMA2 C7 TNXB

3.92e-08200737c338a08c1605527ab9aaf62ea151a19e8469dc6d
ToppCellControl_saline-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|Control_saline / Treatment groups by lineage, cell group, cell type

DOCK4 FBN1 DST ABCA6 TEX15 C7 TNXB

3.92e-08200737bd8cf33502adea320e91ca2af14e1911d88ad374
ToppCell367C-Fibroblasts-Fibroblast-D-|367C / Donor, Lineage, Cell class and subclass (all cells)

FBN1 ABCA6 EFEMP2 LAMA2 ADAM29 TNXB

2.05e-07154736dd3d34f065820e706515a13619f19a5b12734c8e
ToppCell367C-Fibroblasts-Fibroblast-D|367C / Donor, Lineage, Cell class and subclass (all cells)

FBN1 ABCA6 EFEMP2 LAMA2 ADAM29 TNXB

2.05e-071547364bfda1c41efbb86d829b3797d1168bf2587c3c97
ToppCellAdult-Mesenchymal-chondrocyte|Adult / Lineage, Cell type, age group and donor

FBN1 ABCA6 LAMA2 GRIA2 C7 TNXB

2.48e-071597363f7305ee76447064b5c846c4f576360a2f7e0b7c
ToppCellrenal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

FBN1 ABCA6 LAMA2 TEX15 C7 TNXB

3.43e-071687364b2d29a7843bf45922038c093ca7ec0600756adc
ToppCellrenal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

SNED1 FASN FBN1 LAMA2 C7 PCDH10

3.81e-07171736972fab891135bd755d5526cbc5a963200067b0a6
ToppCellrenal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

FBN1 ABCA6 LAMA2 TEX15 C7 TNXB

3.81e-071717365d31fc9b60329d4ae3c77e4ca679359d9314397d
ToppCellrenal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

SNED1 FASN FBN1 LAMA2 C7 PCDH10

3.81e-071717362a77ed79c6f2e700e789c80451a70ecb31639719
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

FBN1 ABCA6 LAMA2 TEX15 C7 TNXB

4.36e-07175736795a6564d5a75ffd35d39f5274b9e8d28708bbc8
ToppCellLA-01._Fibroblast_I|LA / Chamber and Cluster_Paper

SNED1 FBN1 ABCA6 LAMA2 C7 TNXB

4.98e-07179736dcb6ec9ae72b13fe388b72dace2815293fafe8ee
ToppCellAdult-Mesenchymal-matrix_fibroblast_2_cell-D231|Adult / Lineage, Cell type, age group and donor

SNED1 FBN1 ABCA6 LAMA2 C7 TNXB

6.03e-07185736fb6bd7e849ecf4ed9cd9c4e2a946a2d12d62f804
ToppCellCOVID-19-Fibroblasts-Adventitial_FB|COVID-19 / group, cell type (main and fine annotations)

SNED1 FBN1 ABCA6 LAMA2 C7 TNXB

6.03e-07185736a5aebf2b9b05b550d021272731d68af9a6b1229d
ToppCell5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

FBN1 DST ABCA6 LAMA2 C7 TNXB

6.23e-071867365473283fb95cee556b1f6934cf72169b676b5bcc
ToppCell5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

SNED1 FBN1 ABCA6 LAMA2 C7 TNXB

6.84e-07189736d531399749409d614adca13d181830c6e3287508
ToppCellFetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

DOCK4 DST ABCA6 LAMA2 C7 CSMD3

6.84e-07189736203c80030df08ae112f9ae4043709f455d87ce89
ToppCellLV-01._Fibroblast_I|World / Chamber and Cluster_Paper

SNED1 FBN1 ABCA6 LAMA2 C7 TNXB

7.05e-0719073612992ec80a7b4f4f17de693f0719ee061a9918fd
ToppCellControl-Fibroblasts|Control / group, cell type (main and fine annotations)

FBN1 DST ABCA6 LAMA2 C7 TNXB

7.05e-071907363a42a9b98d954685d38a741f44545898d0e3e9ce
ToppCellPND01-03-samps-Mesenchymal-Matrix_fibroblast-MatrixFB-A|PND01-03-samps / Age Group, Lineage, Cell class and subclass

DOCK4 FBN1 ABCA6 PEG3 ADAMTS17 CNN2

7.27e-07191736e7c605b56934d1383237c1f946dbccef25d91368
ToppCellLV-02._Fibroblast_II|World / Chamber and Cluster_Paper

SNED1 FBN1 ABCA6 LAMA2 C7 TNXB

7.27e-07191736d36565257ccba8c1bbed2c1c01be66a9cbb5f834
ToppCell5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-mLN_Stroma_(FMO2+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

FBN1 ABCA6 EFEMP2 LAMA2 C7 TNXB

7.27e-071917364e4488380379ed29d7898bae4e24221e7c67eb9d
ToppCellRV-01._Fibroblast_I|World / Chamber and Cluster_Paper

SNED1 FBN1 ABCA6 ADAMTS17 LAMA2 C7

7.27e-0719173670c067c54084bfb02c29bab085f4defd477194fb
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

FBN1 ABCA6 LAMA2 C7 PCDH10 TNXB

7.50e-07192736bc84b9ce01b4d826a682842ab8a395dac9b91183
ToppCellCOVID-19-Heart-Fib_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type

SNED1 FBN1 ABCA6 LAMA2 C7 TNXB

7.50e-0719273660b1312e84f6d6448365a952469c506c00b5fe93
ToppCelldroplet-Kidney-nan-18m-Mesenchymal-fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

FBN1 ABCA6 EFEMP2 LAMA2 TNXB PCDH9

7.50e-0719273684149a5c6c3b3c9b86aed77cf8e72d99ef099fab
ToppCellAdult-Mesenchymal-matrix_fibroblast_2_cell|Adult / Lineage, Cell type, age group and donor

SNED1 FBN1 ABCA6 LAMA2 C7 TNXB

7.50e-07192736d21f0f577156f17c899b08871046a26b88aea011
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

FBN1 ABCA6 LAMA2 C7 PCDH10 TNXB

7.50e-071927360ab1176cfbb0de8dd1f22c6e2c41265cf6c10ee1
ToppCellCOVID-19-Fibroblasts-Other_FB|COVID-19 / group, cell type (main and fine annotations)

SNED1 FBN1 DST ABCA6 SUGCT LAMA2

7.73e-07193736e6b75be08e33c1de079fb5c02f0b4468128b369c
ToppCellLV-01._Fibroblast_I|LV / Chamber and Cluster_Paper

SNED1 FBN1 ABCA6 LAMA2 C7 TNXB

7.73e-07193736dc17f3b9758936d428cf17f77a1ce6d4c479b165
ToppCellMesenchymal-matrix_fibroblast_1_cell|World / Lineage, Cell type, age group and donor

SNED1 FBN1 DST ABCA6 LAMA2 C7

7.73e-07193736acad568621ed677031797b8c2e34dafea798d681
ToppCellChildren_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor

SNED1 FBN1 ABCA6 LAMA2 C7 TNXB

7.73e-07193736261cafc167c86ab277be4ea7f08b0173e2dde26e
ToppCellRV-02._Fibroblast_II|RV / Chamber and Cluster_Paper

SNED1 FBN1 ABCA6 LAMA2 C7 TNXB

7.96e-0719473611c79a8c56ece42713b04b321982e41e239f07a5
ToppCellControl-Fibroblasts-Intermediate_pathological_FB|Control / group, cell type (main and fine annotations)

FBN1 DST ABCA6 SUGCT LAMA2 C7

7.96e-0719473603a269f75a481ea54aea8e6444605db8d6df493d
ToppCellLV-02._Fibroblast_II|LV / Chamber and Cluster_Paper

SNED1 FBN1 ABCA6 LAMA2 C7 TNXB

7.96e-07194736014d2feb5db2a6a35ef759761a41e466e108c3c1
ToppCellCOVID-19-Heart-Fib_2|Heart / Disease (COVID-19 only), tissue and cell type

SNED1 FBN1 ABCA6 LAMA2 C7 TNXB

7.96e-07194736d91c9f2ec47319051fc398320693fddbe8bbd4d6
ToppCell(5)_Fibroblast-C_(Myofibroblast)|World / Lung cell shreds - cell class (v4) and cell subclass (v4)

FBN1 DST ABCA6 EFEMP2 LAMA2 C7

7.96e-0719473629a72e565c19407bbd198cfbc2a78106fe830d05
ToppCellLA-02._Fibroblast_II|LA / Chamber and Cluster_Paper

SNED1 FBN1 ABCA6 LAMA2 C7 TNXB

7.96e-07194736234d1494c114cce77c619708bbcd8d5ce805f19b
ToppCellChildren_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor

SNED1 FBN1 ABCA6 LAMA2 C7 TNXB

8.21e-07195736ff0aa455e9844a6d7ae57ff59fb6cea825cf1fc2
ToppCellPND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

SNED1 FBN1 PEG3 ADAMTS17 C7 CNN2

8.21e-071957361c1135be421af98cd0077bec1ff2c4158d42aa21
ToppCellCOVID-19-Heart-Fib_1|Heart / Disease (COVID-19 only), tissue and cell type

SNED1 FBN1 ABCA6 LAMA2 C7 TNXB

8.21e-07195736f423baa36ac7cdc383c033e35a7d17e6bf913323
ToppCellPND10-Mesenchymal-Mesenchymal_structural|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

SNED1 FBN1 PEG3 ADAMTS17 C7 CNN2

8.21e-0719573611d421bbbb71425d59cbdd673e052e00d5f0a768
ToppCellLA-02._Fibroblast_II|World / Chamber and Cluster_Paper

SNED1 FBN1 ABCA6 LAMA2 C7 TNXB

8.21e-07195736a78b605b49acd8c9d68716266ca269dafcd910b9
ToppCell5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

FBN1 DST ABCA6 LAMA2 C7 TNXB

8.21e-07195736df409f94f4e83be89f7a608058ee07ce3ce3a149
ToppCellAdult-Mesenchymal-matrix_fibroblast_1_cell|Adult / Lineage, Cell type, age group and donor

FBN1 DST ABCA6 LAMA2 C7 TNXB

8.21e-0719573661c9e09fc84d1012e472185d70ad0a06cee30d6e
ToppCell5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

FBN1 DST ABCA6 LAMA2 C7 TNXB

8.21e-071957364243190ad291d56694e2155954dbaa879c9d3844
ToppCell3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

FBN1 ABCA6 EFEMP2 LAMA2 C7 TNXB

8.21e-071957361236dc60288c7dd91868e86e9174a2dacd3b11b3
ToppCellPND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

SNED1 FBN1 PEG3 ADAMTS17 C7 CNN2

8.21e-071957361f005ee1da66b539bd200aaa98f46edbbc7f12e4
ToppCellPND10-Mesenchymal-Mesenchymal_structural-Fibroblastic|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

SNED1 FBN1 PEG3 ADAMTS17 C7 CNN2

8.21e-0719573610f307aef8f4d9e71c501d5bcedb84d3be7a4d1b
ToppCellrenal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

FBN1 ABCA6 LAMA2 C7 TNXB SAMD4A

8.45e-071967362b36b9a40fe415917afccff99ad9c3474e087d0d
ToppCell5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

FBN1 DST ABCA6 LAMA2 C7 TNXB

8.45e-0719673642e9828222a9663525d571633e8a454c30bfa7f8
ToppCellChildren_(3_yrs)-Mesenchymal|Children_(3_yrs) / Lineage, Cell type, age group and donor

FBN1 DST ABCA6 LAMA2 C7 TNXB

8.45e-07196736bc94909f9b2dc08a59eef1914148b69720569c8f
ToppCell5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.4.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

FASN FBN1 ABCA6 LAMA2 C7 TNXB

8.45e-07196736988a3e0688e0a7ba69774497d3b130631bb26c50
ToppCellLPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type

SNED1 FBN1 DST ABCA6 C7 TNXB

8.71e-07197736fdb92985f7df0c280b87d3e43c2394e70786a2c7
ToppCellPCW_13-14-Mesenchymal|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung

SNED1 FBN1 DST ABCA6 LAMA2 C7

8.71e-0719773673a2085d2682d636726a5432d572ae2a3fbe1c3f
ToppCell3'-GW_trimst-1.5-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

FBN1 ABCA6 PEG3 GRIA2 C7 TNXB

8.71e-071977366b6440f1baad5680cf9e13ca3ab72a2c65523d59
ToppCell3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

SNED1 FBN1 ABCA6 LAMA2 C7 TNXB

8.71e-07197736c747c496ac090309b7f8a3e9d840928f12c83f2f
DrugProcyclidine hydrochloride [1508-76-5]; Down 200; 12.4uM; PC3; HT_HG-U133A

SUGCT EFEMP2 CAPRIN1 PCDH9 ENTPD4 NSD3 KLHL22

3.28e-061977374233_DN
DrugCefotetan [69712-56-7]; Up 200; 7uM; PC3; HT_HG-U133A

A1CF PGLYRP4 ATP8A1 EFEMP2 GRM3 SAMD4A KLHL22

3.39e-061987373997_UP
DrugHeptaminol hydrochloride [543-15-7]; Up 200; 22uM; PC3; HT_HG-U133A

ZKSCAN1 PEG3 LAMA2 THSD1 HNRNPU NSD3 KLHL22

3.39e-061987377313_UP
DrugTrichostatin A, from Streptomyces sp.; Up 200; 0.1uM; HL60; HT_HG-U133A

DOCK4 ATP8A1 DAB2 TEX15 ALDH6A1 PCDH9

3.54e-051927362450_UP
DrugAcetaminophen [103-90-2]; Up 200; 26.4uM; HL60; HT_HG-U133A

SNED1 NXPE4 TSHR ALDH6A1 SAMD4A KLHL22

3.97e-051967363025_UP
DrugIopamidol [60166-93-0]; Up 200; 5.2uM; MCF7; HT_HG-U133A

TRAPPC10 NCBP1 ALDH6A1 PCDH9 ENTPD4 SAMD4A

3.97e-051967363473_UP
DrugIpratropium bromide [22254-24-6]; Up 200; 9.8uM; PC3; HT_HG-U133A

A1CF FBN1 PGLYRP4 TEX15 ALDH6A1 SAMD4A

4.09e-051977365823_UP
DrugCloperastine hydrochloride [14984-68-0]; Down 200; 11uM; MCF7; HT_HG-U133A

DOCK4 NCBP1 TAB1 HNRNPU NSD3 KLHL22

4.09e-051977364732_DN
DrugHeliotrine [303-33-3]; Down 200; 12.8uM; PC3; HT_HG-U133A

IVNS1ABP ATP8A1 NCBP1 KIF3C NSD3 SAMD4A

4.09e-051977364277_DN
DrugStreptomycin sulfate [3810-74-0]; Down 200; 2.8uM; PC3; HT_HG-U133A

EFEMP2 TRAPPC10 THSD1 ALDH6A1 CEMIP2 NSD3

4.21e-051987365837_DN
DrugS(-)Eticlopride hydrochloride [97612-24-3]; Up 200; 10.6uM; HL60; HT_HG-U133A

KIF3C TSHR ALDH6A1 PCDH9 SAMD4A KLHL22

4.45e-052007363056_UP
Drug3-isoxazolol

GRIA2 GRM3

6.06e-054732CID009964065
Drugsunifiram

GRIA2 GRM3

6.06e-054732CID004223812
Drug4-(chloromethyl)-3-methoxy-5-methylisoxazole

GRIA2 GRM3

6.06e-054732CID011105661
Drug4-CO

FBN1 CIAO3

6.06e-054732CID000446968
DrugAC1L1YEG

GRIA2 GRM3

1.01e-045732CID000063114
DrugChicago acid

GRIA2 GRM3

1.01e-045732CID000065740
DrugCHEBI:570577

GRIA2 GRM3

1.01e-045732CID011334126
Drug1-BCP

GRIA2 GRM3

1.01e-045732CID000001370
Drugirampanel

GRIA2 GRM3

1.01e-045732CID003038472
Drugbeta-N-oxalylaminoalanine

GRIA2 GRM3

1.01e-045732CID000107978
DrugLY395153

GRIA2 GRM3

1.01e-045732CID000656707
Drug5-h PCA

GRIA2 GRM3

1.01e-045732CID000129091
Diseaserefractive error, age at onset, Myopia

FBN1 LAMA2 API5 GRM3 DSCAML1 NPLOC4

8.57e-06193736EFO_0004847, HP_0000545, MONDO_0004892
Diseaseaortic aneurysm (is_implicated_in)

FBN1 EFEMP2

1.81e-053732DOID:3627 (is_implicated_in)
DiseaseWeill-Marchesani syndrome (implicated_via_orthology)

FBN1 ADAMTS17

1.81e-053732DOID:0050475 (implicated_via_orthology)
DiseaseWeill-Marchesani syndrome

FBN1 ADAMTS17

3.61e-054732cv:C0265313
DiseaseWeill-Marchesani syndrome (is_implicated_in)

FBN1 ADAMTS17

3.61e-054732DOID:0050475 (is_implicated_in)
Diseasevisual epilepsy (implicated_via_orthology)

ERBB4 C7 VDAC2

8.23e-0534733DOID:11832 (implicated_via_orthology)
Diseaseinterleukin 4 measurement

SUGCT ADAM29 GRM3

9.78e-0536733EFO_0008184
Diseasecarbonic anhydrase-related protein 10 measurement

CELSR2 C7

1.67e-048732EFO_0020233
Diseasemitral valve prolapse (is_implicated_in)

FBN1 TSHR

2.15e-049732DOID:988 (is_implicated_in)
DiseaseAbnormality of refraction

FBN1 ZKSCAN1 LAMA2 API5 GRM3 PCDH9 DSCAML1 NPLOC4

2.56e-04673738HP_0000539
Diseasegestational age

ERBB4 A1CF SUGCT GRM3

3.88e-04138734EFO_0005112
Diseasecardiomyopathy (is_implicated_in)

TSHR DGAT1

1.00e-0319732DOID:0050700 (is_implicated_in)
Diseasepain

CELSR2 SUGCT LAMA2 PCDH9

1.44e-03196734EFO_0003843
Diseaseretinal vasculature measurement

ERBB4 UBXN4 ZKSCAN1 LAMA2 DSCAML1 NPLOC4

1.77e-03517736EFO_0010554
Diseasegastroesophageal reflux disease

ERBB4 ADAMTS17 PCDH9

2.03e-03101733EFO_0003948
Diseaseganglion cell inner plexiform layer thickness measurement

ALDH6A1 NPLOC4

2.19e-0328732EFO_0600005

Protein segments in the cluster

PeptideGeneStartEntry
GYIVVGAGNNQQFAT

SUGCT

286

Q9HAC7
GGFQGILQINDFAYE

ADAM29

121

Q9UKF5
GNQFVYRDGGFAAEQ

ERBB4

1061

Q15303
PIYGRTSGNGFNFND

CSMD3

2881

Q7Z407
FNGNNRGYAFVTFSN

A1CF

91

Q9NQ94
DGMGRYNVFNFQNVG

GRM3

461

Q14832
FENRNGTDGLSYNGA

ABCA6

936

Q8N139
NLGNFNYEQRGAFRG

API5

491

Q9BZZ5
GNARGQFYLDAQTGA

CELSR2

441

Q9HCU4
AWFVGRFFQGNYGNA

DGAT1

441

O75907
QRDGYQQNFKRGSGQ

CAPRIN1

666

Q14444
NLNYGGASNFGLNFL

ATP8A1

331

Q9Y2Q0
QNEEYGGARYLGNNQ

ADAMTS17

311

Q8TE56
VRFIYGGCGGNRNNF

APLP2

336

Q06481
DYFGQQFDQISNRTG

DAB2

341

P98082
FRGDTNFYGKQGIQF

ALDH6A1

491

Q02252
YGQVQVFGFTISQGQ

NOL9

146

Q5SY16
HRFGGQGNQFSYIQS

FLG2

301

Q5D862
QSPNGRYQFNFHEGQ

HAPLN3

171

Q96S86
GLLNARNYNFGGEFV

NCBP1

91

Q09161
DAINNAAGFGFRGYD

MBOAT2

296

Q6ZWT7
TFDGVIYGFNVNAGN

MTIF2

566

P46199
NTIYAVGGFDGNEFL

IVNS1ABP

606

Q9Y6Y0
GDNKYRFFLGNQFGD

DST

7301

Q03001
LQGFNGTVFAYGQTG

KIF3C

86

O14782
QFGGANVSGFQIVDY

GRIA2

251

P42262
QFNDRKQYGSNEGHF

PCDH9

1191

Q9HC56
QGYNNISLGFAFFGT

PGLYRP4

141

Q96LB8
EFGFQNNGFSVYINR

NPLOC4

36

Q8TAT6
NYNQNFRGRGNNRGY

HNRNPU

781

Q00839
ANAQRGTYFDGTGFA

LAMA2

2936

P24043
YFSLDVQTQGDGNRF

PCDH10

166

Q9P2E7
GQRFYAGGSERSGQQ

NSFL1C

91

Q9UNZ2
IQQRVYEGNAFRGGF

PEG3

361

Q9GZU2
YEGNAFRGGFRFNST

PEG3

366

Q9GZU2
VDYFFQRQHGEQLGG

PUM1

81

Q14671
VYLIGGDNNVQGFRA

KLHL22

351

Q53GT1
AAVNGGVSRYQEAFF

DOCK4

1511

Q8N1I0
NSIFNGNQGGVYIFG

FBXO11

541

Q86XK2
QYGVVVQAFNRAGTG

DSCAML1

1061

Q8TD84
GFQYEQFSGGCQDIN

FBN1

2636

P35555
RQFDGSAFGANYSSQ

CRTC3

116

Q6UUV7
GVFYDANDVGFQRNI

B3GALNT2

161

Q8NCR0
GNGYNELTGQFRNRV

C7

141

P10643
FVGESRNYGFQGGQN

CEMIP2

831

Q9UHN6
GAYNAFQIRAGNSQG

EFEMP2

371

O95967
RGNAGQSNYGFANSA

FASN

2026

P49327
NAVYTFGLGQFGQLG

RPGR

261

Q92834
GVFNGYDGNRVTNFV

TAB1

66

Q15750
NQGYDRVIFTGQFVN

NXPE4

196

Q6UWF7
YVATFLGFGGNAARQ

ENTPD4

321

Q9Y227
IAAQAGFNAGDGQRY

SNED1

211

Q8TER0
DGSYFQINQDGGTRR

CIAO3

46

Q9H6Q4
FKCNGNGNEFYLGNS

C12orf56

241

Q8IXR9
NQSGQVFGLGRQIYD

CNN2

256

Q99439
FNVRNGYGFINRNDT

YBX2

101

Q9Y2T7
FNVRNGYGFINRNDT

YBX1

66

P67809
FDVERNSCNNFIYGG

SPINT2

151

O43291
FQYFDGANGTLRNVS

THSD1

46

Q9NS62
QFDHFLVQYRNGDGQ

TNXB

3086

P22105
TRNNFAVGYRTGDFQ

VDAC2

176

P45880
IRGEGFSQANQFNYG

PKHD1L1

51

Q86WI1
GNNTVRFNPNFYRNG

UBE2Z

171

Q9H832
QYPNGSANGFGAVRN

NSD3

91

Q9BZ95
GLYINRGDCFFQLGN

TTC16

366

Q8NEE8
RQENYGSAFPQGGEN

ZKSCAN1

256

P17029
FVTGGQRGQFYQCDL

WDR26

461

Q9H7D7
GFQQQSNFYPGFQGR

TEX15

1736

Q9BXT5
ALFSQYVVNFGAGDG

TRAPPC10

251

P48553
QEGYQNQGQGFQSRD

RPTN

626

Q6XPR3
RQFAAQTVGNTYGNF

UBXN4

346

Q92575
NYNESRGGQSNFNRG

VIRMA

1736

Q69YN4
GYRQQRNRGFGQSNS

SAMD4A

566

Q9UPU9
NNGFTSVQGYAFNGT

TSHR

186

P16473